Dysregulation of the JAK/STAT pathway has been shown to be involved in many immunological defects, including the enhancement of inflammatory cytokines in autoimmune diseases [13, 50], and has thus become one of the key therapeutic targets for inflammatory and autoimmune diseases. Here, SOAT1 is linked to autoimmune disease.